You have 9 free searches left this month | for more free features.

refractory/relapsed acute myelogenous leukemia

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Leukemia, Myeloid, Acute, Relapsed Adult AML, Refractory Leukemia Trial in Xiamen (venetoclax combining chidamide and

Recruiting
  • Leukemia, Myeloid, Acute
  • +2 more
  • venetoclax combining chidamide and azacitidine (VCA)
  • Xiamen, Fujian, China
    Bing Xu
Aug 1, 2022

High Risk Myelodysplastic Syndrome, Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Houston

Completed
  • High Risk Myelodysplastic Syndrome
  • +2 more
  • Daratumumab
  • Houston, Texas
    M D Anderson Cancer Center
Nov 21, 2022

Refractory Leukemia, Relapsed Leukemia, Acute Myelogenous Leukemia Trial in Miami (STING-Dependent Activators (STAVs) Loaded

Not yet recruiting
  • Refractory Leukemia
  • +4 more
  • STING-Dependent Activators (STAVs) Loaded Autologous Leukemic Cells
  • Dendritic Cell Vaccine
  • Miami, Florida
    University of Miami
Jan 23, 2023

Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Philadelphia Chromosome Positive, Recurrent Acute Lymphoblastic

Active, not recruiting
  • Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 2, 2022

Acute Myelogenous Leukemia in Relapse, Acute Myelogenous Leukemia, Relapsed, Adult, Acute Myelogenous Leukemia, Adult Trial in

Terminated
  • Acute Myelogenous Leukemia in Relapse
  • +4 more
  • Tucson, Arizona
  • +12 more
Aug 18, 2022

Acute Myelogenous Leukemia, MDS Trial in Shanghai (Gentulizumab)

Recruiting
  • Acute Myelogenous Leukemia
  • Myelodysplastic Syndromes
  • Shanghai, Shanghai, China
    Ruijin Hospital, Shanghai Jiao Tong University School of Medicin
Feb 22, 2022

Juvenile Myelomonocytic Leukemia, Recurrent Acute Biphenotypic Leukemia, Recurrent Acute Undifferentiated Leukemia Trial in

Suspended
  • Juvenile Myelomonocytic Leukemia
  • +27 more
  • CD8+ and CD4+ Donor Memory T-cells-expressing HA1-Specific TCR
  • +2 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jan 11, 2023

AML Trial in Hangzhou (MAX-40279-01)

Recruiting
  • AML
  • Hangzhou, Zhejiang, China
    The First Affiliated Hospital, Zhejiang University
Jan 18, 2022

Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia, Biphenotypic Acute Leukemia Trial in Minneapolis (biological, drug,

Not yet recruiting
  • Acute Myelogenous Leukemia
  • +17 more
  • Peripheral Blood Stem Cell Transplant
  • +7 more
  • Minneapolis, Minnesota
    Masonic Cancer Center at University of Minnesota
Mar 27, 2023

Ex Vivo Drug Sensitivity Testing and Mutation Profiling

Completed
  • Recurrent Childhood Acute Myeloid Leukemia
  • +13 more
    • Miami, Florida
      Nicklaus Children's Hospital
    Jan 18, 2023

    Recurrent Acute Leukemia, Recurrent B Acute Lymphoblastic Leukemia, Recurrent Blastic Plasmacytoid Dendritic Cell Tumor Trial in

    Recruiting
    • Recurrent Acute Leukemia
    • +16 more
    • Duarte, California
      City of Hope Medical Center
    Nov 22, 2022

    AML, Advanced MDS, ALL Trial in Chicago, New York (OTS167IV)

    Terminated
    • AML
    • +4 more
    • Chicago, Illinois
    • +1 more
    Nov 15, 2021

    Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Lymphoblastic Leukemia, BCR-ABL1 Fusion Protein

    Recruiting
    • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
    • +7 more
    • Blinatumomab
    • +3 more
    • Houston, Texas
      M D Anderson Cancer Center
    Dec 31, 2022

    Acute Myeloid Leukemia, Chronic Myeloid Leukemia, Acute Lymphocytic Leukemia Trial in Indianapolis (Fludarabine + Total Marrow

    Recruiting
    • Acute Myeloid Leukemia
    • +3 more
    • Fludarabine + Total Marrow Irradiation
    • Indianapolis, Indiana
      Indiana University Melvin and Bren Simon Comprehensive Cancer Ce
    Jun 1, 2022

    Lymphoblastic Leukemia, Acute, Childhood, Myelogenous Leukemia, Acute, Childhood Trial in United States (AC220, Cytarabine,

    Completed
    • Lymphoblastic Leukemia, Acute, Childhood
    • Myelogenous Leukemia, Acute, Childhood
    • Los Angeles, California
    • +10 more
    Mar 24, 2022

    Leukemia, Acute Myeloid, MDS, Classical Hodgkin Lymphoma Trial in United States (MGD024)

    Recruiting
    • Leukemia, Acute Myeloid
    • +7 more
    • Denver, Colorado
    • +4 more
    Aug 29, 2022

    Acute Myeloid Leukemia, Leukemia, Acute Myeloid, Myeloid Leukemia, Acute Trial in Canada, United States (Iomab-B, Conventional

    Active, not recruiting
    • Acute Myeloid Leukemia
    • +8 more
    • Gilbert, Arizona
    • +23 more
    Feb 22, 2022

    High-risk MDS, Acute Myelogenous Leukemia, Systemic Mastocytosis Trial in Minneapolis, Madison (GTB-3550 TriKE® Phase I,

    Terminated
    • High-risk Myelodysplastic Syndromes
    • +3 more
    • GTB-3550 TriKE® Phase I
    • GTB-3550 TriKE® Phase II
    • Minneapolis, Minnesota
    • +1 more
    Mar 21, 2022

    Acute Myeloid Leukemia, AML, Adult, Multiple Myeloma Trial in United States (FT538, Cyclophosphamide, Fludarabine)

    Recruiting
    • Acute Myeloid Leukemia
    • +3 more
    • Denver, Colorado
    • +8 more
    May 19, 2022

    Acute Myelogenous Leukemia Trial in Fuzhou, Shanghai (SH1573 Capsules)

    Recruiting
    • Acute Myelogenous Leukemia
    • SH1573 Capsules
    • Fuzhou, Fujian, China
    • +1 more
    Mar 17, 2021

    Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Lymphoblastic Lymphoma Trial in Valhalla, Charlotte (Clofarabine,

    Active, not recruiting
    • Acute Lymphoblastic Leukemia
    • +4 more
    • Valhalla, New York
    • +1 more
    Oct 29, 2021

    Acute Myeloid Leukemia, Chronic Myeloid Leukemia, Acute Lymphocytic Leukemia Trial in Indianapolis (Fludarabine, Total Marrow

    Terminated
    • Acute Myeloid Leukemia
    • +3 more
    • Indianapolis, Indiana
      Indiana University Melvin & Bren Simon Cancer Center
    Feb 22, 2022

    Leukemia Trial in Duarte (drug, procedure, radiation)

    Active, not recruiting
    • Leukemia
    • Duarte, California
      City of Hope Medical Center
    Mar 17, 2022

    Myelogenous Leukemia, Acute Trial in Ramat Gan (Bisantrene, Fludarabine, Clofarabine)

    Recruiting
    • Myelogenous Leukemia, Acute
    • Ramat Gan, Israel
      Chaim Sheba Medical Center
    Sep 21, 2021

    Leukemia, Acute Lymphocytic (ALL), Leukemia, Acute Myelogenous (AML), MDS Trial in Guangzhou (Chimeric antigen receptor T cells,

    Recruiting
    • Leukemia, Acute Lymphocytic (ALL)
    • +2 more
    • Chimeric antigen receptor T cells
    • peptide specific dendritic cell
    • Guangzhou, Guangdong, China
      Zhujiang Hospital, Southern Medical University
    Aug 1, 2021